Comparative characteristics of embolization and ligation of the right branch of the portal vein (literature review)
Open Access
- 17 May 2025
- journal article
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (2) , 144-149
Abstract
The purpose of the study was to compare the methods of mechanical reduction of blood flow in the right branch of the portal vein: portal vein embolization (PVE) and portal vein ligation (PVL) as a neoadjuvant treatment before extended hepatectomy to induce hypertrophy of the future liver remnant (FLR) for the prevention of post-resection hepatic failure (PRHF). Material and Methods. A total of 28 publications from PubMed and ScienceDirect databases, the International Hepato-Pancreato-Biliary Association, monographs and guidelines for physicians, covering the period from 2001 to 2004, were analyzed. The search for articles in the PubMed database was conducted using the key words: “portal vein embolization” and “portal vein ligation” with the parameters “Free full text”, “Review”, “5 years”. 22 articles were selected as relevant. Conclusion. In general, no clear and unanimous opinion was found among the authors regarding the rate of FLR hypertrophy between the PVE and PVL methods. However, most authors recommended PVL. As for the time interval from PVE/PVL to the second stage of surgery, the opinions were equally bipolar. Many authors recommended additional segment IV embolization to enhance the regenerative potential, which is associated with technical difficulties and requires advanced skills. The problem of post-occlusion tumor progression was widely reported, the highest percentage of cases was described after PVE. This fact is explained by hemodynamic restructuring, stimulation of cytokine and growth factor production. The cases of insufficient FLR hypertrophy due to the development of intrahepatic collaterals, especially after PVL, were described. Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) was proposed as an alternative to prevent this complication. Complications after PVE/PVL were poorly described, with isolated reports of contralateral embolization, intra-abdominal choleraemia or hemorrhage, and distant periportal fibrosis. To date, PVE remains the gold standard as the first stage of two-stage extensive liver resections, as a prevention of post-resection liver failure.Keywords
This publication has 27 references indexed in Scilit:
- Oncological benefits of portal vein embolization for patients with hepatocellular carcinomaAnnals of Gastroenterological Surgery, 2020
- Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinomaInternational Journal of Surgery, 2020
- Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resectionHPB, 2020
- Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysisSurgical Oncology, 2017
- Rapid Liver Hypertrophy After Portal Vein Occlusion Correlates with the Degree of Collateralization Between Lobes—a Study in PigsJournal of Gastrointestinal Surgery, 2017
- A review of animal models for portal vein embolizationJournal of Surgical Research, 2014
- Portal Vein Embolization and Ligation for Extended HepatectomyIndian Journal of Surgical Oncology, 2014
- Effect of portal vein embolisation on the growth rate of colorectal liver metastasesBritish Journal of Cancer, 2009
- Is embolization of segment 4 portal veins before extended right hepatectomy justified?Surgery, 2008
- Preoperative Portal Embolization in Patients with Hepatocellular CarcinomaWorld Journal of Surgery, 2001